← All trials

NCT05322577

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
May 17, 2022
Primary completion
Mar 17, 2026
Completion date
Apr 1, 2028
First posted
Apr 12, 2022
Last posted
Nov 8, 2024
Enrollment
80
Arms / groups
4 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.